The NC1-H69 human small cell lung carcinoma line. The antibody binding epitope has been mapped to the first EGF-like repeat domain (EGF1) amino acids 27-59 of the EpCAM protein (Balzar, 1999; Balzar 2001).
Conjugate
Alexa Fluor 488
Applications
Application Notes
Flow Cytometry (5 μl/test/106 cells (0.2 ug)) & The optimal working dilution should be determined by the end user.
Target
Alternative Names
EPCAM; epithelial cell adhesion molecule; antigen identified by monoclonal AUA1 , M4S1, MIC18, TACSTD1, tumor associated calcium signal transducer 1; 17 1A; 323/A3; CD326; CO 17A; EGP 2; EGP34; EGP40; Ep CAM; ESA; GA733 2; HEA125; KS1/4; KSA; Ly74; MH99;
This gene encodes a carcinoma-associated antigen and is a member of a family that includes at least two type I membrane proteins. This antigen is expressed on most normal epithelial cells and gastrointestinal carcinomas and functions as a homotypic calcium-independent cell adhesion molecule. The antigen is being used as a target for immunotherapy treatment of human carcinomas. Mutations in this gene result in congenital tufting enteropathy.
Citations
Publication ()
Have you cited DCABH-11419 in a publication? Let us know and earn a reward for your research.
Q: What substance was used to create the Anti-EPCAM monoclonal antibody, clone WV2E0 [Alexa Fluor® 488]?
A: The NC1-H69 human small cell lung carcinoma line. The antibody binding epitope has been mapped to the first EGF-like repeat domain (EGF1) amino acids 27-59 of the EpCAM protein (Balzar, 1999; Balzar 2001).
Customer Reviews
My Review for Anti-EPCAM monoclonal antibody, clone WV2E0 [Alexa Fluor® 488]
Creative Diagnostics products are for RESEARCH USE ONLY, please make sure your review is research based.
Required fields are marked with *
Terms and conditions:
We will select high-quality review customers and offer a $30 coupon for your next purchase.
All product reviews must be submitted in the English language.
Creative Diagnostics will not share any personal information of applicants, and all information will be treated with strict confidentiality and will not be sold or disclosed to a third party.
COA
Publication 
Loading ......
